Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 20 clinical trials
Study of Surufatinib Single Agent or Surufatinib Combined With Toripalimab in Patients With Advanced Solid Tumors

This is a phase II, single arm, open-label, multicenter study to evaluate the efficacy and safety of Surufatinib single agent or Surufatinib combined with Toripalimab in patients with advanced

  • 0 views
  • 24 Feb, 2022
  • 2 locations
Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

A phase II study to assess the efficacy and safety of Surufatinib or Surufatinib combined with Vinorelbine as third-line and posterior line treatment in patients with NSCLC

  • 0 views
  • 21 Aug, 2021
  • 1 location
A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine Carcinoma

To evaluate the efficacy of Surufatnib combined with Toripalimab compared with FOLFIRI in the treatment of advanced neuroendocrine carcinoma

  • 0 views
  • 07 Oct, 2021
  • 1 location
Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study

A phase II study to assess the efficacy and safety of Surufatinib combined with Sintilimab as a second-line treatment in patients with advanced MSS-Type CRC.

  • 0 views
  • 15 Nov, 2021
  • 1 location
Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer

A phase II study to assess the efficacy and safety of Surufatinib Combined With Toripalimab and Chemotherapy as a first-line treatment in patients with advanced non-squamous non-small cell lung

carboplatin
cancer chemotherapy
egfr t790m
targeted therapy
pemetrexed
  • 0 views
  • 24 Mar, 2022
  • 1 location
Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer

The objective is to investigate the efficacy and safety of Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer.

  • 0 views
  • 26 Jun, 2021
  • 5 locations
Efficacy and Safety of Neoadjuvant Surufatinib for Patients With Salivary Gland Carcinomas

The objective is to investigate the efficacy and safety of Surufatinib Neoadjuvant Therapy for Locally Advanced Primary Saliary Gland Adenocarcinoma.

  • 0 views
  • 28 Aug, 2021
  • 1 location
Open-Label Surufatinib in European Patients With NET

This is a Phase 2, open-label, multi-centre study of surufatinib in patients with low to intermediate grade (Grade 1 or Grade 2), well-differentiated neuroendocrine tumours (NETs).

  • 0 views
  • 11 Mar, 2022
  • 12 locations
Open-label Study of Surufatinib in Japanese Patients

This is a phase 1/2, open-label, multi-centre study of surufatinib in patients with unresectable, locally advanced, or recurrent nonhematologic malignancies who do not respond or are intolerant

  • 0 views
  • 25 Mar, 2022
  • 11 locations
Surufatinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

This is a non-randomized, phase II, open label study of Surufatinib hydrochloride capsules in recurrent/metastatic adenocarcinomas of head and neck. The primary purpose of this study is to

  • 0 views
  • 13 Jun, 2021
  • 1 location